JACOBSON PHARMA News

JACOBSON PHARMA: JOINT ANNOUNCEMENT REVISION OF THE EXISTING ANNUAL CAPS FOR THE CONTINUING CONNECTED TRANSACTIONS UNDER THE 2023 MANUFACTURING SERVICES AGREEMENT

Apr 2 08:06 ET

JACOBSON PHARMA: JOINT ANNOUNCEMENT CONNECTED TRANSACTION TRANSFER OF 19% EQUITY INTERESTS IN THE TARGET COMPANY

Oct 3, 2023 08:48 ET

JACOBSON PHARMA: JOINT ANNOUNCEMENT RENEWAL OF CONTINUING CONNECTED TRANSACTIONS

Mar 3, 2023 06:28 ET

Jacobson Pharma Corporation: CONNECTED TRANSACTION FURTHER AMENDMENT TO THE FACILITY AGREEMENT

Oct 26, 2022 10:14 ET

Jacobson Pharma Corporation: CONNECTED TRANSACTION AMENDMENT TO THE FACILITY AGREEMENT

Oct 25, 2022 06:57 ET

Jacobson Pharma Corporation: SUPPLEMENTAL ANNOUNCEMENT CONNECTED TRANSACTION PROVISION OF SHAREHOLDER''S LOAN TO A COMPANY AND POTENTIAL SUBSCRIPTION OF NEW SHARES IN A COMPANY BY WAY OF LOAN CAPITALISATION

Jul 28, 2022 07:33 ET

Jacobson Pharma Corporation: CONNECTED TRANSACTION PROVISION OF SHAREHOLDER''S LOAN TO A COMPANY AND POTENTIAL SUBSCRIPTION OF NEW SHARES IN A COMPANY BY WAY OF LOAN CAPITALISATION

Jul 18, 2022 06:54 ET

Jacobson Pharma Corporation: CONNECTED TRANSACTION PROVISION OF LOAN FACILITY

Jun 6, 2022 06:15 ET

Jacobson Pharma Corporation: CONTINUING CONNECTED TRANSACTIONS

Jul 8, 2021 07:52 ET

Jacobson Pharma Corporation: COMPLETION ANNOUNCEMENT

Jul 30, 2020 06:32 ET

Jacobson Pharma Corporation: CONNECTED TRANSACTIONS (1) INCREASE IN SHAREHOLDING HELD IN ORIZEN CAPITAL LIMITED (2) DEEMED DISPOSAL OF EQUITY INTERESTS IN A SUBSIDIARY

Jul 27, 2020 08:46 ET

Jacobson Pharma Corporation: DISCLOSEABLE TRANSACTION IN RELATION TO THE DISPOSAL OF 49% OF EQUITY INTERESTS IN HONG NING HONG LIMITED AND DISPOSAL OF SUBSIDIARY

Jun 1, 2020 05:33 ET

Jacobson Pharma Corporation: CONNECTED TRANSACTION ACQUISITION OF THE ENTIRE ISSUED SHARE CAPITAL OF THE TARGET COMPANY

Jan 17, 2020 09:00 ET

Jacobson Pharma Corporation: PROFIT GUARANTEE IN RESPECT OF THE ACQUISITION OF 70% OF EQUITY INTERESTS IN HONG NING HONG LIMITED

Aug 9, 2019 07:25 ET

Jacobson Pharma Corporation: DISCLOSEABLE TRANSACTION IN RELATION TO THE ACQUISITION OF 43% OF THE ISSUED SHARE CAPITAL OF ORIZEN CAPITAL LIMITED

Jul 22, 2019 10:49 ET